Table 4. Clinical chorioamnionitis predictors of adverse
neonatal outcomes in study participants with chorioamnionitis. Crude and
adjusted Odds ratios with corresponding 95% confidence intervals.
|
Chorioamnionitis = 500 |
Chorioamnionitis = 500 |
|
|
|
No neonatal infection
N 448
|
Neonatal infectiona
N 52
|
OR (95% CI)
Crude
|
OR (95% CI)b
Adjusted
|
No temp. ≥38.0°C |
48 (10.7) |
6 (11.5) |
Reference (1.0) |
Reference (1.0) |
≥ 1 temp 38.0-38.9°C |
400 (89.3) |
46 (88.5) |
0.92 (0.37-2.27) |
0.90
(0.36-2.23) |
Temp 38.0-38.9°C ≥30 minutes |
211 (47.1) |
31 (59.6) |
1.66 (0.92-2.97) |
1.58 (0.88-2.85) |
≥ 1 temp ≥ 39.0°C |
104 (23.2) |
10 (19.2) |
0.79 (0.38-1.62) |
0.80
(0.39-1.66) |
Leukocyte count first |
|
|
|
|
≤14.7 |
137/395 (34.7) |
12/48 (25.0) |
Reference (1.0) |
Reference (1.0) |
14.8-19.2 |
121/395 (30.6) |
24/48 (50.0) |
2.26 (1.09-4.72) |
2.14 (1.02-4.49) |
>19.2 |
137/395 (34.7) |
12/48 (25.0) |
1.00 (0.43-2.30) |
0.90 (0.39-2.10) |
Leukocytes, highest |
|
|
|
|
≤17.0 |
131/395 (33.2) |
15/48 (31.3) |
Reference (1.0) |
Reference (1.0) |
17.1-21.5 |
131/395 (33.2) |
18/48 (37.5) |
1.2 (0.58-2.48) |
1.07
(0.51-2.23) |
>21.5 |
133/395 (33.7) |
15/48 (31.3) |
0.98 (0.46-2.09) |
0.90 (0.42-1.93) |
CRP first |
|
|
|
|
≤33 |
128/384 (33.3) |
15/47 (31.9) |
Reference (1.0) |
Reference (1.0) |
34-109 |
132/384 (34.4) |
13/47 (27.7) |
0.84 (0.39-1.84) |
0.79
(0.36-1.74) |
>109 |
124/384 (32.3) |
19/47 (40.4) |
1.31 (0.64-2.69) |
1.24 (0.60-2.56) |
CRP, highest |
|
|
|
|
≤147 |
136/384 (35.4) |
7/47 (14.9) |
Reference (1.0) |
Reference (1.0) |
148-232 |
129/384 (33.6) |
16/47 (34.1) |
2.41 (0.96-6.05) |
2.36 (0.94-5.95) |
>232 |
119/384 (31.0) |
24/47 (51.1) |
3.92
(1.63-9.42) |
4.01 (1.66-9.68) |
Fetal tachycardia |
291/441 (66.0) |
41/52 (78.9) |
1.91 (0.96-3.84) |
1.99 (0.99-4.00) |
Positive cervical culture |
113/316 (35.7) |
20/36 (55.6) |
2.25
(1.20-4.51) |
2.22 (1.10-4.48) |